Karim Saad Temsamani - Apr 5, 2023 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Chief Executive Officer, Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Apr 5, 2023
Transactions value $
$0
Form type
4
Date filed
4/12/2023, 05:30 PM
Previous filing
Sep 1, 2022
Next filing
Jul 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDLX Restricted Stock Units Award $0 +200K $0.00 200K Apr 5, 2023 Common Stock 200K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F2 25% of the RSUs shall vest on each of July 1, 2023, October 1, 2023, January 1, 2024 and April 1, 2024, respectively, subject to the Reporting Person's continuous service with the Issuer through each applicable vesting date.